血管生成
血管内皮生长因子
受体酪氨酸激酶
胎盘生长因子
激酶插入结构域受体
血管内皮生长因子受体
酪氨酸激酶
血管内皮生长因子A
化学
癌症研究
医学
信号转导
细胞生物学
生物
内科学
受体
生物化学
作者
Monica Autiero,Johannes Waltenberger,Didier Communi,Andrea Kranz,Lieve Moons,Diether Lambrechts,Jens Krøll,Stéphane Plaisance,Maria De Mol,Françoise Bono,Stefanie Kliche,Guido Fellbrich,Kurt Ballmer‐Hofer,Domenico Maglione,Ulrike Mayr-Beyrle,Mieke Dewerchin,Saskia Dombrowski,Danica Stanimirovic,Paul Van Hummelen,Christoph Dehio
出处
期刊:Nature Medicine
[Nature Portfolio]
日期:2003-06-08
卷期号:9 (7): 936-943
被引量:762
摘要
Therapeutic angiogenesis is likely to require the administration of factors that complement each other. Activation of the receptor tyrosine kinase (RTK) Flk1 by vascular endothelial growth factor (VEGF) is crucial, but molecular interactions of other factors with VEGF and Flk1 have been studied to a limited extent. Here we report that placental growth factor (PGF, also known as PlGF) regulates inter- and intramolecular cross talk between the VEGF RTKs Flt1 and Flk1. Activation of Flt1 by PGF resulted in intermolecular transphosphorylation of Flk1, thereby amplifying VEGF-driven angiogenesis through Flk1. Even though VEGF and PGF both bind Flt1, PGF uniquely stimulated the phosphorylation of specific Flt1 tyrosine residues and the expression of distinct downstream target genes. Furthermore, the VEGF/PGF heterodimer activated intramolecular VEGF receptor cross talk through formation of Flk1/Flt1 heterodimers. The inter- and intramolecular VEGF receptor cross talk is likely to have therapeutic implications, as treatment with VEGF/PGF heterodimer or a combination of VEGF plus PGF increased ischemic myocardial angiogenesis in a mouse model that was refractory to VEGF alone.
科研通智能强力驱动
Strongly Powered by AbleSci AI